| An inhibitor of Bcl-2 family proteins induces regression of solid tumours T Oltersdorf, SW Elmore, AR Shoemaker, RC Armstrong, DJ Augeri, ... Nature 435 (7042), 677-681, 2005 | 4051 | 2005 |
| Discovering high-affinity ligands for proteins: SAR by NMR SB Shuker, PJ Hajduk, RP Meadows, SW Fesik Science 274 (5292), 1531-1534, 1996 | 2750 | 1996 |
| ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor C Tse, AR Shoemaker, J Adickes, MG Anderson, J Chen, S Jin, ... Cancer research 68 (9), 3421-3428, 2008 | 2183 | 2008 |
| Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis M Sattler, H Liang, D Nettesheim, RP Meadows, JE Harlan, M Eberstadt, ... Science 275 (5302), 983-986, 1997 | 2060 | 1997 |
| X-ray and NMR structure of human Bcl-x L, an inhibitor of programmed cell death SW Muchmore, M Sattler, H Liang, RP Meadows, JE Harlan, HS Yoon, ... Nature 381 (6580), 335-341, 1996 | 2045 | 1996 |
| Promoting apoptosis as a strategy for cancer drug discovery SW Fesik Nature Reviews Cancer 5 (11), 876-885, 2005 | 1387 | 2005 |
| Bcl-x L forms an ion channel in synthetic lipid membranes AJ Minn, P Vélez, SL Schendel, H Liang, SW Muchmore, SW Fesik, M Fill, ... Nature 385 (6614), 353-357, 1997 | 1180 | 1997 |
| Structural basis for the inhibition of caspase-3 by XIAP SJ Riedl, M Renatus, R Schwarzenbacher, Q Zhou, C Sun, SW Fesik, ... Cell 104 (5), 791-800, 2001 | 1093 | 2001 |
| Pleckstrin homology domains bind to phosphatidylinositol-4, 5-bisphosphate JE Harlan, PJ Hajduk, HS Yoon, SW Fesik Nature 371 (6493), 168-170, 1994 | 1045 | 1994 |
| Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain Z Liu, C Sun, ET Olejniczak, RP Meadows, SF Betz, T Oost, J Herrmann, ... Nature 408 (6815), 1004-1008, 2000 | 860 | 2000 |
| Heteronuclear three-dimensional NMR spectroscopy. A strategy for the simplification of homonuclear two-dimensional NMR spectra SW Fesik, ERP Zuiderweg Journal of Magnetic Resonance (1969) 78 (3), 588-593, 1988 | 579 | 1988 |
| Discovery of small molecules that bind to K‐Ras and inhibit Sos‐mediated activation Q Sun, JP Burke, J Phan, MC Burns, ET Olejniczak, AG Waterson, T Lee, ... Angewandte Chemie International Edition 51 (25), 6140-6143, 2012 | 548 | 2012 |
| NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP C Sun, M Cai, AH Gunasekera, RP Meadows, H Wang, J Chen, H Zhang, ... Nature 401 (6755), 818-822, 1999 | 532 | 1999 |
| NMR structure and mutagenesis of the Fas (APO-1/CD95) death domain B Huang, M Eberstadt, ET Olejniczak, RP Meadows, SW Fesik Nature 384 (6610), 638-641, 1996 | 525 | 1996 |
| Insights into programmed cell death through structural biology SW Fesik Cell 103 (2), 273-282, 2000 | 488 | 2000 |
| Structure and ligand recognition of the phosphotyrosine binding domain of Shc MM Zhou, KS Ravichandran, ET Olejniczak, AM Petros, RP Meadows, ... Nature 378 (6557), 584-592, 1995 | 468 | 1995 |
| Discovery of potent nonpeptide inhibitors of stromelysin using SAR by NMR PJ Hajduk, G Sheppard, DG Nettesheim, ET Olejniczak, SB Shuker, ... Journal of the American Chemical Society 119 (25), 5818-5827, 1997 | 463 | 1997 |
| Drugging an undruggable pocket on KRAS D Kessler, M Gmachl, A Mantoulidis, LJ Martin, A Zoephel, M Mayer, ... Proceedings of the National Academy of Sciences 116 (32), 15823-15829, 2019 | 352 | 2019 |
| Discovery of potent myeloid cell leukemia 1 (Mcl-1) inhibitors using fragment-based methods and structure-based design A Friberg, D Vigil, B Zhao, RN Daniels, JP Burke, PM Garcia-Barrantes, ... Journal of medicinal chemistry 56 (1), 15-30, 2013 | 316 | 2013 |
| NMR structure and mutagenesis of the FADD (Mort1) death-effector domain M Eberstadt, B Huang, Z Chen, RP Meadows, SC Ng, L Zheng, ... Nature 392 (6679), 941-945, 1998 | 308 | 1998 |
